Lv5
1115 积分 2021-02-07 加入
Discovery of AMG 193, an MTA-Cooperative PRMT5 Inhibitor for the Treatment of MTAP-Deleted Cancers
1天前
已完结
Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader
5天前
已完结
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
5天前
已完结
Essential role of Stat6 in IL-4 signalling
5天前
已完结
Safety, Pharmacokinetics, and Efficacy of TY-9591 (Deuterated Osimertinib Derivative) in Advanced EGFR-mutated Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation and Dose-Expansion Study
19天前
已完结
Guidelines for the treatment of psoriasis with biologics and small-molecule drugs in China （2024）
22天前
已完结
Selective degradation of multimeric proteins by TRIM21-based molecular glue and PROTAC degraders
24天前
已完结
Discovery of the Clinical Candidate YY2201 as a Highly Potent and Selective ATR Inhibitor
26天前
已完结
Small molecule targeted protein degradation via the UPS: venturing beyond E3 substrate receptors
1个月前
已完结
Turning Off STAT6 with a Targeted Degrader
1个月前
已完结
皖公网安备34019202002308
